Purple Biotech (PPBT)

Purple Biotech (PPBT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5M; returns 1 day +2.9%, 1 week -5.3%, 1 year -81.3%.

Purple Biotech is a clinical-stage, pre-revenue Israeli biotechnology company focused on developing first-in-class cancer therapies designed to overcome tumor immune evasion and drug resistance. As it does not yet have commercial products, its business model is entirely dependent on research and development funded by capital raised through public offerings.

Groups PPBT belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Israel Companies
• Oncology
• Clinical Stage
• Cancer Therapeutics
• Israel
• Healthcare
• Immunotherapy
• Antibody Therapeutics
• Monoclonal Antibodies
• Pancreatic Cancer

PPBT financial model: income statement, cash flow and balance sheet